![]() |
SUPERIOR HANDLING
|
![]() |
![]() |
UNRIVALLED RESULTS WITH HIGH REPRODUCIBILITY 1
|
|
![]() |
HIGH FLEXIBILITY
|
|
![]() |
MAXIMUM SAFETY
1 Scientifically tested serum concentrations (TU Munich) |
The IMPACT system offers the user the opportunity of producing various autologous cell therapies with only one platform. Autologous cell therapies – internationally also known as orthobiologics – use the body’s own physiological regeneration mechanisms. They contain growth factors, anti-inflammatory cytokines or stem cells in concentrated form, for example. After injection to the defect, they assist the body in an absolutely natural way to heal the injured tissue. |
The innovative technology of IMPACT permits the production of variable concentrations of leukocytes and thrombocytes. And that, by means of a very simple automated production process. Scientifically tested IMPACT programs with specific parameters are recommended for each therapeutic objective. In addition, the system also permits the physician to define and store own program variants. With the IMPACT system the physician can offer numerous different autologous cell therapies. Thus, the patients’ individual therapeutic needs are met even better. |
Very easy handling![]() |
Reliable technology for reproducible resultsIMPACT centrifuges and separates the requested blood fractions fully automated and in a closed system. The sensitivity of the optical sensor installed can be adjusted. Thus, the optical sensor separates reliably and precisely. The syringe with the patient’s blood is laid in, and after the program has been completed, the requested autologous “ready-to-use” blood product is removed. ![]() |
Technical dataDimensions (H × W × D): 456 x 555 x 707 mm Capacity: 2 x 12 ml Max. RPM: 2.800 Max. RCF: 940 Operation by intuitive user-friendly touch display |
Innovative technology |
The IMPACT system can be used to produce a number of different autologous cell therapies at the push of a button. The selection is made depending on the respective therapeutic objective. Single-use treatment sets are available for different therapeutic applications:
Without anticoagulant for the production of slightly concentrated platelet-rich plasma
With anticoagulant for the production of highly concentrated platelet concentrate
For the production of an autologous conditioned serum
Autologous cell therapies make use of the natural endogenous mechanisms for the regeneration and healing of injured tissue. The body’s response to an injury is a complex healing cascade in order to heal the wound as quickly as possible. To understand how this regeneration process runs down, the cellular level has to be looked into. Histologically, three types of cells can be discerned in the blood: Erythrocytes responsible for the transportation of oxygen and carbon dioxide; leukocytes which divide up into different types and regulate the immune defense; as well as thrombocytes, also referred to as blood platelets Platelets are responsible for hemostasis, and mediate the first phases of wound healing. In this phase, platelets aggregate and form the blood clot. In addition, growth factors are released by degranulation of thrombocytes. |
The release of cellular growth factors supports healing by
Leukocytes form several cytokines, referred to as interleukins. They mediate between leukocytes and play an important role in immune defense. This is where autologous cell therapies come in: From the patient’s whole blood those cells, cytokines or growth factors are isolated and concentrated, which promise the best therapeutic outcome for the initial diagnosis. They are brought to the site of the injury or defect, and support the physiological regeneration and healing process. IMPACT is the innovative platform for autologous cell therapies and permits the largest possible diversity of therapies and flexibility. |